Drug
Posaconazole KG
Posaconazole KG: highest development phase Phase 2, developed by Merck. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Merck
Trials
| Drug | Phase | Indication |
|---|---|---|
| Posaconazole IV 6 mg/kg NCT04665037 | Phase 2 | Invasive Fungal Infection |
Latest
No recent events.
Follow Posaconazole KG on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.